Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Quaglino

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 17, 2013
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatosesP Quaglino, R Ponti, M Novelli, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 10, 2024
Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of DiseaseM Bertello, E Cinotti, P Rubegni, et al.
The British Journal of Dermatology|February 21, 1998
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous diseaseP Savoia, M T Fierro, M Novelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2020
Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelinesE Papadavid, J Scaribrick, P Ortiz Romero, et al.
Journal of Cutaneous Pathology|July 5, 2001
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patientsM T Fierro, M Novelli, P Savoia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2017
Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous LymphomasV Grandi, P Fava, S Rupoli, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevanceG C Doveil, M T Fierro, M Novelli, et al.
British Journal of Cancer|October 17, 2003
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patientsS Osella-Abate, P Savoia, P Quaglino, et al.
Clinical & Experimental Metastasis|February 6, 2002
In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis inductionB Salomone, R Ponti, M R Gasco, et al.
The British Journal of Dermatology|January 21, 2015
The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosumM Caproni, E Antiga, W Volpi, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 17, 2013
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatosesP Quaglino, R Ponti, M Novelli, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 10, 2024
Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of DiseaseM Bertello, E Cinotti, P Rubegni, et al.
The British Journal of Dermatology|February 21, 1998
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous diseaseP Savoia, M T Fierro, M Novelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2020
Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelinesE Papadavid, J Scaribrick, P Ortiz Romero, et al.
Journal of Cutaneous Pathology|July 5, 2001
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patientsM T Fierro, M Novelli, P Savoia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2017
Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous LymphomasV Grandi, P Fava, S Rupoli, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevanceG C Doveil, M T Fierro, M Novelli, et al.
British Journal of Cancer|October 17, 2003
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patientsS Osella-Abate, P Savoia, P Quaglino, et al.
Clinical & Experimental Metastasis|February 6, 2002
In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis inductionB Salomone, R Ponti, M R Gasco, et al.
The British Journal of Dermatology|January 21, 2015
The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosumM Caproni, E Antiga, W Volpi, et al.
Pageof 16